Protagonist Therapeutics Stock Forecast

Hold candidate since Jun 03, 2026

The Protagonist Therapeutics Inc stock price gained 2.34% on the last trading day (Wednesday, 3rd Jun 2026), rising from $93.23 to $95.41. During the last trading day the stock fluctuated 2.81% from a day low at $93.00 to a day high of $95.61. The price has been going up and down for this period, and there has been a -3.01% loss for the last 2 weeks. Volume fell on the last day by -157 thousand shares and in total, 554 thousand shares were bought and sold for approximately $52.89 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $93.27 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.59% during the next 3 months and, with a 90% probability hold a price between $95.69 and $110.14 at the end of this 3-month period.

PTGX Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 02, 2026, and so far it has risen 2.34%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Protagonist Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $97.96 and $100.95. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Protagonist Therapeutics Inc stock

Protagonist Therapeutics Inc finds support from accumulated volume at $94.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $2.61 between high and low, or 2.81%. For the last week, the stock has had daily average volatility of 4.23%.

Our recommended stop-loss: $90.74 (-4.89%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (PTGX) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Protagonist Therapeutics Inc to open at $94.67, and during the day (based on 14 day Average True Range), to move between $93.36 and $97.46, which gives a possible trading interval of +/-$4.10 (+/-4.39%) up or down from last closing price. If Protagonist Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 4.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $94.92 (0.51%) than the resistance at $97.09 (1.76%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Protagonist Therapeutics Inc stock A Buy?

Protagonist Therapeutics Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: 0.570 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $94.67 ( 0.772%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk